All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...857Next →

hiv & aids news selected from other sources

  • Tuberculosis and HIV
    UNAIDS reports mixed progress towards reaching the 2020 target of reducing TB deaths among people living with HIV by 75%
    UNAIDS press release | 7 hours ago

    Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action.

  • Access to medicines and treatment
    Interview With Charles Gore, Medicines Patent Pool Executive Director
    Intellectual Property Watch | 24 March 2019

    Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

  • New and experimental HIV treatments
    Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
    Motley Fool | 24 March 2019

    RBC Capital Markets analyst Brian Abrahams specifically mentioned a somewhat surprising reason to be excited about Gilead's prospects. He thinks that experimental HIV drug GS-6207 could be a transformative catalyst for Gilead. But GS-6207 is only in phase 1 clinical testing. It could take years for the drug to reach the market.

  • Structural factors
    Education and HIV incidence among girls in Africa – a strong association but still no evidence of causation
    AVERT | 22 March 2019

    Education is a critical component of young women’s health and empowerment programmes – but we need to be careful not to assume an immediate direct effect on HIV incidence.

  • PrEP policies and guidelines
    Rapidly Starting PrEP Before All Labs Are Back Proves Feasible in NYC
    Poz | 21 March 2019

    Waiting for all lab tests to return before prescribing Truvada resulted in a high dropout rate among those visiting sexual health clinics.

  • PrEP programmes and uptake
    PrEP Use Among Gay and Bi Men Hits a New High
    Poz | 21 March 2019

    A third of at-risk gay and bi men are now using Truvada for HIV prevention, the CDC says.

  • Tuberculosis and HIV
    The Lancet: Experts set out targets to eliminate tuberculosis within a generation
    Eurekalert Inf Dis | 21 March 2019

    A world free of tuberculosis (TB) is possible by 2045 if increased political will and financial resources are directed towards priority areas including providing evidence-based interventions to everyone, especially to high risk groups, and increasing research to develop new ways to diagnose, treat, and prevent TB. Funding this response will require substantial investments, and accountability mechanisms will be necessary to ensure that promises are kept and targets are reached.

  • Confidentiality, consent and medical ethics
    “I have HIV, now what?” Tracking cookies found on NHS advice pages
    New Statesman | 20 March 2019

    Invasive tracking technology been covertly installed on more than a dozen NHS landing pages about sensitive medical conditions, new research has revealed.

  • New and experimental HIV treatments
    Trogarzo’s Effects on Hard-to-Treat HIV Are Stable Over Two Years
    Poz | 20 March 2019

    Researchers followed a small group of people with highly drug-resistant virus taking Trogarzo (ibalizumab-uiyk) plus an optimized background regimen.

  • Activism
    A Farewell to Project Inform from HIV Research Advocate David Evans
    My Fabulous Disease | 18 March 2019

    The HIV community was dealt a sad blow this week when it was announced that the iconic non-profit HIV treatment advocacy organization, Project Inform, will end its programs. Project Inform’s Director of Research Advocacy, David Evans, has been working with the organization in various capacities for the last 27 years. In this message shared with My Fabulous Disease, David reflects on Project Inform’s legacy and on the influence of its legendary founder, Martin Delaney. We must all honor this legacy by ensuring that HIV treatment advocacy remain at the forefront of our movement.

← First12345...6Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2019).


Watch our AIDS 2018 aidsmapLIVE panel discussion on YouTube.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.